Newsroom

IrakExploEn_une
Vidéos
Programme 3D

The MSF Foundation is exploring patient follow-up possibilities in Baghdad and northern Iraq

UneMotionAntibiogo
Vidéos
Antibiogo

All about Antibiogo, a free application to counter AMR

Utilisation d'Antibiogo au laboratoire MSF, hôpital CHK.Kinshasa. République Démocratique du Congo
Articles
Antibiogo

Antibiogo is already implemented in routine in DRC and Jordan, and soon within other MSF’s Labs !

Read more
Articles
Antibiogo

Antibiogo is looking for a User Experience Researcher (Freelance)

We are looking for a User Experience Researcher to join Antibiogo team and work on the future development of the application

Read more
Articles
Antibiogo

[Freelance] Antibiogo is looking for a Backend Developer (Typescript) and a Computer vision Engineer

We are looking for a Backend Developer (Typescript) and a Computer vision Engineer to join Antibiogo team and work on the development of the application’s new features

Read more
Miniature TIC
Vidéos
Antibiogo

[ANTIBIOGO] Antibiogo : A free diagnostic aid application to counter antibiotic resistance.

Headline

Antibiogo 3
Articles
Antibiogo

Antibiogo ISO 13485 Certified, a First for a Humanitarian Project

In 2025, the Antibiogo application is seeing wide deployment, extending beyond MSF field operations. After being adopted by all MSF laboratories in 2024, the tool has also been integrated by local health authorities in several countries: Burkina Faso, Comoros, Guinea, Liberia, Mali, Central African Republic, Democratic Republic of the Congo, and Benin. This expansion marks a new era for Antibiogo: scaling up.

At the same time, the project team continued efforts to reach the highest level of quality standards, culminating in obtaining ISO 13485 certification. This unprecedented level of requirement for an NGO project reflects the excellence of the management practices implemented for this medical device project, for which MSF Foundation is the legal manufacturer.

Read more

MSF Foundation in Video

More articles

News

More articles

Publications

  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
More articles

Press Review

More articles
No news for now.